UnitedHealth Group Incorporated $UNH Shares Bought by BCGM Wealth Management LLC

BCGM Wealth Management LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 59.0% in the second quarter, HoldingsChannel reports. The fund owned 6,355 shares of the healthcare conglomerate’s stock after purchasing an additional 2,359 shares during the quarter. BCGM Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,983,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Tsfg LLC lifted its stake in UnitedHealth Group by 10.0% during the second quarter. Tsfg LLC now owns 572 shares of the healthcare conglomerate’s stock valued at $179,000 after purchasing an additional 52 shares during the last quarter. Westside Investment Management Inc. lifted its stake in UnitedHealth Group by 17.2% during the second quarter. Westside Investment Management Inc. now owns 4,016 shares of the healthcare conglomerate’s stock valued at $1,254,000 after purchasing an additional 589 shares during the last quarter. Torray Investment Partners LLC raised its holdings in shares of UnitedHealth Group by 126.3% during the second quarter. Torray Investment Partners LLC now owns 49,337 shares of the healthcare conglomerate’s stock valued at $15,392,000 after acquiring an additional 27,539 shares during the period. EPG Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 12.2% during the second quarter. EPG Wealth Management LLC now owns 2,390 shares of the healthcare conglomerate’s stock valued at $746,000 after acquiring an additional 259 shares during the period. Finally, Sigma Planning Corp raised its holdings in shares of UnitedHealth Group by 3.9% during the second quarter. Sigma Planning Corp now owns 15,631 shares of the healthcare conglomerate’s stock valued at $4,876,000 after acquiring an additional 583 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.0%

Shares of NYSE:UNH opened at $341.46 on Monday. The stock has a market capitalization of $309.31 billion, a PE ratio of 17.82, a P/E/G ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a fifty day moving average price of $343.51 and a 200 day moving average price of $325.81. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the prior year, the company posted $7.15 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.2% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on UNH. Mizuho boosted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Truist Financial upped their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Barclays upped their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. KeyCorp upped their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Finally, Morgan Stanley upped their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.